REDUCE III: Cutting Balloon angioplasty before stenting reduces in-stent restenosis more than standa
Washington, DC - As Cutting Balloon TM (Boston Scientific, Natick, MA) angioplasty has struggled to find a niche in the world of interventional cardiologyespecially in light of two previous randomized ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
The LMCA was engaged with an EBU 4 6 Fr guiding catheter through right radial approach.10000U of heparin was given. An Asahi soft guidewire was placed in Cx and balloon predilatation was made by 2x15 ...
SAN FRANCISCO — A sirolimus-eluting balloon was found to be noninferior to conventional stenting in separate trials of patients undergoing percutaneous coronary interventions (PCIs), suggesting these ...
Treatment of coronary in-stent restenosis is hampered by a high incidence of recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated balloon in this setting.
Leverages Abbott's Market-Leading MULTI-LINK Stent Design and Cobalt Chromium Alloy for the Treatment of Iliac Artery Disease Expands Abbott's Offerings of Innovative Therapies for Treatment of ...
Dr. Mehran is a co-Principal Investigator of the breakthrough "SELUTION4ISR Trial," with results presented at Transcatheter Cardiovascular Therapeutics 2025. A new drug-eluting balloon can perform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results